亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

濟南偉都化工科技有限公司  

學校 工廠

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:小楊
  • 電話:0531-88682202
  • QQ:1158262190
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 112885-42-4
112885-42-4
單價 面議對比
詢價 暫無
發貨 山東濟南市付款后3天內
品牌 枸櫞酸莫沙必利 112885-42-4
型號 112885-42-4
規格 枸櫞酸莫沙必利 112885-42-4
過期 長期有效
更新 2013-03-05 11:57
 
詳細信息
 
  枸櫞酸莫沙必利 112885-42-4
 
英文名  Mosapride citrate 
別名  4-Amino-5-chloro-2-ethoxy-N-[[4-[(4-fluorophenyl)methyl]-2-morpholinyl]methyl]-benzamide 2-hydroxy-1,2,3-propanetricarboxylate; Gasmotin
產品名稱  枸櫞酸莫沙必利; 4-氨基-5-氯-2-乙氧基-N-[[4-(4-氟芐基)-2-嗎啉基]甲基]苯甲酰胺枸櫞酸鹽

分子式  C21H25ClFN3O3.C6H8O7;C27H33ClFN3O10
分子量  614.02
CAS 登錄號  112885-42-4 
112885-42-4 mosapride citrate 

Name  Mosapride citrate 
Synonyms  4-Amino-5-chloro-2-ethoxy-N-[[4-[(4-fluorophenyl)methyl]-2-morpholinyl]methyl]-benzamide 2-hydroxy-1,2,3-propanetricarboxylate; Gasmotin

Molecular Formula  C21H25ClFN3O3.C6H8O7;C27H33ClFN3O10
Molecular Weight  614.02
CAS Registry Number  112885-42-4 
©2025 濟南偉都化工科技有限公司 版權所有   技術支持:化工網   訪問量:15196  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |